Literature DB >> 22475331

The role of ABC and SLC transporters in the pharmacokinetics of dietary and herbal phytochemicals and their interactions with xenobiotics.

Yan Li1, Jun Lu, James W Paxton.   

Abstract

There is accumulating evidence that many compounds, known as phytochemicals (PCs), which are derived from dietary plants and herbs, may have a role in combating a number of chronic diseases. Despite many in vitro studies elucidating the mechanism(s) of action of various PCs, there are still reservations with regard to their health benefits in vivo, particularly as there is a paucity of research on their oral bioavailability, their pharmacokinetics, and the concentrations achieved at their site(s) of action. Recently various transporters, including the ATP-binding cassette (ABC) and the solute carrier (SLC) transporters, have been cloned and functional analyses have suggested that they play significant roles in the absorption and disposition of most drugs and PCs. While some SLC transporters facilitate absorption of PCs into the systemic circulation, various efflux pumps, including the ABC transporters, actively transport the PC back into the gastro-intestinal (GI) lumen, thus preventing further penetration into the body. Some ABC transporters also act in concert with Phase 1 and 2 metabolizing enzymes as a defensive barrier in the intestines and liver. If the PC overcomes the defence mechanisms of the gut and the liver, it will enter the systemic circulation and be distributed to the other organs of the body and possible site(s) of action. PCs can usually pass with ease through the pores of the capillaries of organs such as the heart and lungs, but with difficulty into pharmacological sanctuaries, such as the brain, testis, or foetus. Such sanctuaries contain a number of efflux transporters in their protective membrane, which restrict the penetration of xenobiotics, including PCs. The ABC and SLC transporters are also abundantly expressed in the liver and kidney and regulate the excretion of many compounds, including PCs and their metabolites. It is also becoming apparent that there is a complex interplay between various PCs and their ability to modulate the activity of these transporters involved in the processes of absorption, metabolism, distribution and excretion, which control the extent of xenobiotic exposure in the body. This review describes the importance of the ABC and SLC transporters in the pharmacokinetics of dietary and herbal PCs, and their interactions with other xenobiotics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22475331     DOI: 10.2174/1389200211209050624

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  10 in total

Review 1.  Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences.

Authors:  Enoche F Oga; Shuichi Sekine; Yoshihisa Shitara; Toshiharu Horie
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-04       Impact factor: 2.441

2.  Herb-drug interactions: challenges and opportunities for improved predictions.

Authors:  Scott J Brantley; Aneesh A Argikar; Yvonne S Lin; Swati Nagar; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

Review 3.  Interplay of drug metabolizing enzymes with cellular transporters.

Authors:  Michaela Böhmdorfer; Alexandra Maier-Salamon; Juliane Riha; Stefan Brenner; Martina Höferl; Walter Jäger
Journal:  Wien Med Wochenschr       Date:  2014-09-10

4.  Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine.

Authors:  Jia-Long Fang; Tao Han; Qiangen Wu; Frederick A Beland; Ching-Wei Chang; Lei Guo; James C Fuscoe
Journal:  Arch Toxicol       Date:  2013-11-30       Impact factor: 5.153

5.  Cellular Pharmacokinetic Model-Based Analysis of Genistein, Glyceollin, and MK-571 Effects on 5 (and 6)-Carboxy-2',7'-Dichloroflourescein Disposition in Caco-2 Cells.

Authors:  Callie Drennen; Erin Gorse; Robert E Stratford
Journal:  J Pharm Sci       Date:  2017-12-14       Impact factor: 3.534

Review 6.  Phytotherapeutics: The Emerging Role of Intestinal and Hepatocellular Transporters in Drug Interactions with Botanical Supplements.

Authors:  Ghulam Murtaza; Naveed Ullah; Farah Mukhtar; Shamyla Nawazish; Saiqa Muneer
Journal:  Molecules       Date:  2017-10-21       Impact factor: 4.411

7.  Risk of Developing Hepatocellular Carcinoma following Depressive Disorder Based on the Expression Level of Oatp2a1 and Oatp2b1.

Authors:  Yan Chen; Jiongshan Zhang; Mengting Liu; Zengcheng Zou; Fenglin Wang; Hao Hu; Baoguo Sun; Shijun Zhang
Journal:  Biomed Res Int       Date:  2019-07-29       Impact factor: 3.411

Review 8.  Multifaceted Factors Causing Conflicting Outcomes in Herb-Drug Interactions.

Authors:  Young Hee Choi; Young-Won Chin
Journal:  Pharmaceutics       Date:  2020-12-30       Impact factor: 6.321

9.  Supplemental Ascorbate Diminishes DNA Damage Yet Depletes Glutathione and Increases Acute Liver Failure in a Mouse Model of Hepatic Antioxidant System Disruption.

Authors:  Colin G Miller; Jean A Kundert; Justin R Prigge; Julie A Amato; Allison E Perez; Lucia Coppo; Gabrielle N Rizzo; Michael P Kavanaugh; David J Orlicky; Colin T Shearn; Edward E Schmidt
Journal:  Antioxidants (Basel)       Date:  2021-02-27

Review 10.  Solute carrier transporters: potential targets for digestive system neoplasms.

Authors:  Jing Xie; Xiao Yan Zhu; Lu Ming Liu; Zhi Qiang Meng
Journal:  Cancer Manag Res       Date:  2018-01-24       Impact factor: 3.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.